EISNER MARK (EVP and Chief Medical Officer) sold 2.2% of their position (3.50K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $34.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/26/2026ACC: 0001628280-26-012394
Officer· EVP and Chief Medical Officer
Since Feb 2026
-3.50K
Net shares
Net seller
$34.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.62K
Price / share
$9.53
Trade value
$15.40K
% of position
1.0%
2/24/2026
157.53K→155.91K
Common Stock
Direct
Shares
−1.89K
Price / share
$9.82
Trade value
$18.55K
% of position
1.2%
2/25/2026
155.91K→154.02K
Total
Net shares
−3.50K
Net value
-$33.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | S · Sale | −1.62K | $9.53 | $15.40K | 1.0% | 157.53K | 155.91K |
| Common Stock Direct | 2/25/2026 | S · Sale | −1.89K | $9.82 | $18.55K | 1.2% | 155.91K | 154.02K |
| Total | −3.50K | -$33.95K | ||||||
Derivative Transactions0
No derivative transactions reported